Author:
Mehta Dev G,Wundes Annette,Strate Lisa L,Romba Meghan C
Funder
National Multiple Sclerosis Society
Reference11 articles.
1. De novo colitis after ocrelizumab therapy;Akram;Gastroenterology,2020
2. Exacerbation of ulcerative colitis after rituximab salvage therapy;Goetz;Inflamm. Bowel Dis.,2007
3. Safety of ocrelizumab in multiple sclerosis: updated analysis in patients with relapsing and primary progressive multiple sclerosis;Hauser,2020
4. FDA approves new kind of lymphoma treatment. food and drug administration;James;AIDS Treat News,1997
5. Clinical features of rituximab-associated gastrointestinal toxicities;Mallepally;Am. J. Clin. Oncol.,2019
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献